ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

S-1 After Surgery Improves Survival, Japanese Trial Finds

February 23, 2007

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration

February 23, 1990

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995